A SECOND “game-changing” Alzheimer’s drug shown to slow the progression of the disease has been approved in the UK. Donanemab, developed by pharmaceutical giant Eli Lilly, was ...

AvenCell Therapeutics announced that it raised $115 million in a Series B round. The company is developing CAR-T therapies ...

Currently, financial markets are experiencing a mix of optimism and caution as investors react to changing economic ...

Donanemab has been described as a game-changer for Alzheimer's, with research showing it slowed its progressions by 35 per ...

Production of Prozac, an antidepressant, would end globally at the end of this year, drugmaker Eli Lilly and Co said in a press release yesterday after announcing in August that the drug would soon be ...

Gov. Eric Holcomb this week said it’s worth sending Hoosier officials abroad to clinch economic development deals — while ...

U.K. regulators will reportedly recommend the NHS not cover Eli Lilly’s (LLY) donanemab for the treatment of early ...

Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), today joined President Joe Biden in Concord, New Hampshire at the New Hampshire Technical Institute for an event on ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...

The historic Zion Baptist Church will receive nearly a quarter of a million dollars to preserve its history and architecture.

In a phase III trial of adults with type 2 diabetes with heart disease and/or chronic kidney disease, oral semaglutide ...